Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits
Authors:
- 1 April 2011
- journal article
- Published by British Editorial Society of Bone & Joint Surgery in The Journal of Bone and Joint Surgery. British volume
- Vol. 93-B (4) , 510-516
Abstract
Several bisphosphonates are now available for the treatment of osteoporosis. Porous hydroxyapatite/collagen (HA/Col) composite is an osteoconductive bone substitute which is resorbed by osteoclasts. The effects of the bisphosphonate alendronate on the formation of bone in porous HA/Col and its resorption by osteoclasts were evaluated using a rabbit model. Porous HA/Col cylinders measuring 6 mm in diameter and 8 mm in length, with a pore size of 100 μm to 500 μm and 95% porosity, were inserted into a defect produced in the lateral femoral condyles of 72 rabbits. The rabbits were divided into four groups based on the protocol of alendronate administration: the control group did not receive any alendronate, the pre group had alendronate treatment for three weeks prior to the implantation of the HA/Col, the post group had alendronate treatment following implantation until euthanasia, and the pre+post group had continuous alendronate treatment from three weeks prior to surgery until euthanasia. All rabbits were injected intravenously with either saline or alendronate (7.5 μg/kg) once a week. Each group had 18 rabbits, six in each group being killed at three, six and 12 weeks post-operatively. Alendronate administration suppressed the resorption of the implants. Additionally, the mineral densities of newly formed bone in the alendronate-treated groups were lower than those in the control group at 12 weeks post-operatively. Interestingly, the number of osteoclasts attached to the implant correlated with the extent of bone formation at three weeks.In conclusion, the systemic administration of alendronate in our rabbit model at a dose-for-weight equivalent to the clinical dose used in the treatment of osteoporosis in Japan affected the mineral density and remodelling of bone tissue in implanted porous HA/Col composites.Keywords
This publication has 31 references indexed in Scilit:
- The Effect of Soaking Allograft in Bisphosphonate: A Pilot Dose-response StudyClinical Orthopaedics and Related Research, 2010
- Effects of gamma‐ray irradiation on mechanical properties, osteoconductivity, and absorption of porous hydroxyapatite/collagenJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2009
- Experimental results of combining bisphosphonates with allograft in a rat modelThe Journal of Bone and Joint Surgery. British volume, 2009
- Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronateThe Journal of Bone and Joint Surgery. British volume, 2008
- Bisphosphonate Delivery to Tubular Bone Allografts2008
- Current trends in bone grafting and the issue of banked bone allografts based on the fourth nationwide survey of bone grafting status from 2000 to 2004Journal of Orthopaedic Science, 2007
- Bone allografts pretreated with a bisphosphonate are not resorbedActa Orthopaedica, 2002
- Oral presentationsActa Orthopaedica, 2002
- In Vitro Evaluation of Highly Absorptive Ceramics Materials Needs Consideration of Calcium and Magnesium Ions Adsorbed to the MaterialsKey Engineering Materials, 2001
- Effects of ethylhydroxydiphosphonate (EHDP) on heterotopic ossificationActa Orthopaedica, 1986